Listing #2984625 oncnursingnews.com

362
The FDA granted a priority review for a Biologics License Application (BLA) to bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...

Category

Website Performance

observedCumulativeLayoutShift 0 Sec
observedSpeedIndexTs 605250326352
observedTraceEndTs 605265112682
observedLargestContentfulPaint 3.1 Sec
observedFirstContentfulPaintTs 605243931500
observedFirstContentfulPaintAllFramesTs 605243931500
largestContentfulPaint 5.52 Sec
observedLastVisualChangeTs 605262638182
observedLoad 16232
observedNavigationStartTs 605243223182
firstContentfulPaint 1.51 Sec
observedTraceEnd 21890
maxPotentialFID 0.75 Sec
observedFirstContentfulPaintAllFrames 0.71 Sec
speedIndex 7.32 Sec
cumulativeLayoutShift 0 Sec
observedLargestContentfulPaintAllFrames 3.1 Sec
observedFirstPaintTs 605243931500
observedTimeOrigin 0 Sec
observedLastVisualChange 19415
observedTotalCumulativeLayoutShift 0 Sec
observedLargestContentfulPaintAllFramesTs 605246325619
observedFirstMeaningfulPaintTs 605246325619
observedNavigationStart 0 Sec
observedLoadTs 605259454748
observedFirstVisualChangeTs 605244139182
observedSpeedIndex 7.1 Sec
observedFirstContentfulPaint 0.71 Sec
observedFirstVisualChange 0.92 Sec
observedDomContentLoaded 0.59 Sec
observedLargestContentfulPaintTs 605246325619
observedFirstMeaningfulPaint 3.1 Sec
observedFirstPaint 0.71 Sec
totalCumulativeLayoutShift 0 Sec
interactive 15164
observedTimeOriginTs 605243223182
firstMeaningfulPaint 2.51 Sec
cumulativeLayoutShiftMainFrame 0 Sec
totalBlockingTime 8.57 Sec
observedDomContentLoadedTs 605243810595
observedCumulativeLayoutShiftMainFrame 0 Sec